Lalande Laure, Galy Guillaume, Dussossoy Emilie, Noyel Jean-Etienne, Pivot Christine
Department of Pharmacy, Hôpital Edouard Herriot, Hospices Civils de Lyon, Lyon, France.
J Infus Nurs. 2012 Sep-Oct;35(5):321-7. doi: 10.1097/NAN.0b013e3182659abd.
Nurses endure daily low-level exposure to cytotoxic drugs, which can lead to significant absorption with potential harmful consequences. New sterile medical devices called cytotoxic safe infusion systems (CSISs), intended by their manufacturers to improve safety and quality of cytotoxic drug infusions, have been made commercially available. CSISs from 3 manufacturers were tested in 2 cancer units and compared with standard infusion sets. The aim of this study is to evaluate the devices regarding occupational exposure, quality of the infusion, and economic aspects.
护士每天都会接触低剂量的细胞毒性药物，这可能导致大量吸收并产生潜在的有害后果。一种名为细胞毒性安全输液系统（CSISs）的新型无菌医疗设备已投入商业使用，其制造商旨在提高细胞毒性药物输液的安全性和质量。来自3家制造商的CSISs在2个癌症科室进行了测试，并与标准输液器进行了比较。本研究的目的是评估这些设备在职业暴露、输液质量和经济方面的情况。
